483 related articles for article (PubMed ID: 37760539)
21. The Developing Story of Predictive Biomarkers in Colorectal Cancer.
Boussios S; Ozturk MA; Moschetta M; Karathanasi A; Zakynthinakis-Kyriakou N; Katsanos KH; Christodoulou DK; Pavlidis N
J Pers Med; 2019 Feb; 9(1):. PubMed ID: 30736475
[TBL] [Abstract][Full Text] [Related]
22. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis.
Søreide K; Watson MM; Lea D; Nordgård O; Søreide JA; Hagland HR;
J Transl Med; 2016 Jun; 14(1):192. PubMed ID: 27357108
[TBL] [Abstract][Full Text] [Related]
23. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA SNHG6 promotes the progression of colorectal cancer through sponging miR-760 and activation of FOXC1.
Zhu Y; Xing Y; Chi F; Sun W; Zhang Z; Piao D
Onco Targets Ther; 2018; 11():5743-5752. PubMed ID: 30254467
[TBL] [Abstract][Full Text] [Related]
25. LINC00294/miR-620/MKRN2 axis provides biomarkers and negatively regulates malignant progression in colorectal carcinoma.
Qi P; Yexie Z; Xue C; Huang G; Zhao Z; Zhang X
Hum Exp Toxicol; 2023; 42():9603271231167577. PubMed ID: 37218161
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
27. LncRNA-ZDHHC8P1 promotes the progression and metastasis of colorectal cancer by targeting miR-34a.
Li C; Liu T; Zhang Y; Li Q; Jin LK
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1476-1486. PubMed ID: 30840269
[TBL] [Abstract][Full Text] [Related]
28. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.
Ji D; Chen Z; Li M; Zhan T; Yao Y; Zhang Z; Xi J; Yan L; Gu J
Mol Cancer; 2014 Apr; 13():86. PubMed ID: 24755295
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer.
Kadowaki S; Kakuta M; Takahashi S; Takahashi A; Arai Y; Nishimura Y; Yatsuoka T; Ooki A; Yamaguchi K; Matsuo K; Muro K; Akagi K
World J Gastroenterol; 2015 Jan; 21(4):1275-83. PubMed ID: 25632202
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability.
Wielandt AM; Hurtado C; Moreno C M; Villarroel C; Castro M; Estay M; Simian D; Martinez M; Vial MT; Kronberg U; López-Köstner F
Tumour Biol; 2020 Jul; 42(7):1010428320938492. PubMed ID: 32635826
[TBL] [Abstract][Full Text] [Related]
32. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
33. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
34. Identification of prognostic long intergenic non-coding RNAs as competing endogenous RNAs with KRAS mutations in colorectal cancer.
Xu J; Huang QY; Ge CJ
Oncol Lett; 2021 Oct; 22(4):717. PubMed ID: 34429757
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA circVAPA is up-regulated and exerts oncogenic properties by sponging miR-101 in colorectal cancer.
Li XN; Wang ZJ; Ye CX; Zhao BC; Huang XX; Yang L
Biomed Pharmacother; 2019 Apr; 112():108611. PubMed ID: 30797148
[TBL] [Abstract][Full Text] [Related]
36. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.
Nguyen VN; Mirejovský P; Mirejovský T; Melínová L; Mandys V
Acta Histochem; 2000 Aug; 102(3):323-38. PubMed ID: 10990069
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
39. Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression.
Liu Y; Tang W; Ren L; Liu T; Yang M; Wei Y; Chen Y; Ji M; Chen G; Chang W; Xu J
J Transl Med; 2022 Mar; 20(1):106. PubMed ID: 35241106
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of microRNA-31 is associated with poor prognosis in patients with advanced colorectal cancer.
Kubota N; Taniguchi F; Nyuya A; Umeda Y; Mori Y; Fujiwara T; Tanioka H; Tsuruta A; Yamaguchi Y; Nagasaka T
Oncol Lett; 2020 Apr; 19(4):2685-2694. PubMed ID: 32218819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
